Background: Velocity ratio, velocity time integral (VTI) ratio, and pulmonary valve area indexed to body surface area (iPVA) are methods of assessment of pulmonary valve stenosis (PS) severity that are less dependent on blood flow. Studies evaluating these methods are limited.
Objectives: To determine the effects of butorphanol, atenolol, and balloon valvuloplasty (BV) on velocity ratio, VTI ratio, iPVA, mean PG, and max PG.
Animals: Twenty-seven dogs with PS (max PG >50 mm Hg).
Methods: Prospective study. All dogs underwent an echocardiogram at baseline, 5-minutes after administration of butorphanol (0.2-0.25 mg/kg IV), and 2-to-4 weeks after atenolol (1-1.5 mg/ kg q12h). Twenty-one of these were evaluated 24-hours after BV.
Results: There were no significant differences (P > .05) amongst any of the methods of assess- Although prospective controlled treatment studies are lacking, many clinicians agree that dogs with clinical signs or severe PS are likely to
Abbreviations: 2D, two-dimensional; AoD, aortic valve diameter; AV, aortic valve; BV, balloon valvuloplasty; CI, cardiac index; CSA, cross-sectional area; PFO, patent foramen ovale; iPVA, pulmonary valve area indexed to body surface area; PV mean PG, pulmonary valve mean pressure gradient; PV max PG, pulmonary valve maximum pressure gradient; PS, pulmonary valve stenosis; PV, pulmonary valve; RV, right ventricle/ventricular; RV S', peak systolic RV myocardial velocity at the lateral tricuspid annulus; SV, stroke volume; iTAPSE, tricuspid annular plane systolic excursion indexed to body weight; V max , maximum velocity; VTI AV , velocity time integral of the aortic valve; VTI PV , velocity time integral of the pulmonary valve benefit from balloon valvuloplasty (BV). [3] [4] [5] Treatment with betablockers such as atenolol might also be recommended depending on the severity of PS or the presence of clinical signs, tachyarrhythmias, or dynamic outflow tract obstruction. Assessment of PS severity plays a pivotal role in the clinical management of dogs with PS including, decisions on when to intervene with treatment, judging effectiveness of BV, and prognosis. 6, 7 The most common and only echocardiographic method mentioned in guidelines 8 published in the veterinary literature to determine the severity of PS is Doppler echocardiography-derived maximum velocity of blood flow across the stenotic pulmonary valve (PV). Maximum velocity is then converted to the PV maximum pressure gradient (PV max PG) using the simplified Bernoulli equation.
Advantages of this method include its ease to acquire and body sizeindependence. However, in addition to the degree of stenosis, pressure gradients are largely influenced by transvalvular flow, as described by Gorlin's formula. 9 Reduced cardiac output caused by, for example, sedatives, anesthetics, negative inotropic drugs, or ventricular systolic dysfunction might underestimate stenosis severity.
9-11
Conversely, high cardiac output states such as stress/anxiety, anemia, heightened sympathetic tone, or after interventional states might overestimate stenosis severity. 9, 10, 12 Current human guidelines 13 recommend an integrative approach for assessment of aortic valve (AV) stenosis severity, and do not recommend solely relying on maximum velocity or pressure gradient. In addition to mean PG and max PG, the continuity equation valve area is recommended for routine assessment. 13 Calculation of valve area is based on the principal that flow volume at different locations in a closed system are equal. 9, 14 Hence, stroke volume (SV) through the PV is equal to SV through the AV, and SV represents the product of cross-sectional area (CSA) and the distance blood moves over the ejection period, called stroke distance or velocity time integral (VTI).
This equation (CSA AV × VTI AV = CSA PV × VTI PV ) can be rewritten to solve for pulmonary valve area (PVA) as: PVA = (CSA AV × VTI AV ) Ä VTI PV . 9, 14 In theory, this method is less dependent on transvalvular flow, representing its major advantage. Disadvantages include the necessity to index to body size, its more time-consuming nature, and the large impact of small measurement errors in estimating CSA. To overcome these limitations, the equation can be simplified by eliminating CSA to determine the VTI ratio (VTI AV /VTI PV ) or maximum velocity ratio (Vmax AV /Vmax PV ). 13, 15 Other than a single case example, 14 a comprehensive evaluation of PVA, VTI ratio, or velocity ratio has not been reported in dogs with PS.
The objective of our study was to determine the effects of butorphanol, atenolol, and BV on PVA, VTI ratio, velocity ratio, PV mean PG, and PV max PG. Butorphanol was selected because it is a commonly used sedative utilized to help facilitate echocardiographic examinations in dogs with PS. Because sedatives and negative inotropic drugs, such as atenolol, are expected to reduce transpulmonic flow, we hypothesized that these drugs would reduce the flowdependent methods of assessment of PS severity (PV mean PG and PV max PG) but would not alter the less flow-dependent methods of assessment of PS severity (PVA, VTI ratio, velocity ratio). Lastly, as proof-of-principal, we expected PVA, VTI ratio, and velocity ratio to be significantly increased after BV.
| MATERIALS AND METHODS

| Animals
Study subjects were client owned dogs that presented to our hospital's cardiology service for evaluation of known or suspected cardiac disease or were referred for the purposes of our study. 
| Echocardiographic measurements and calculations
All echocardiographic measurements were performed by a single car- . 17 
| Echocardiographic repeatability and measurement variability
Within-day repeatability was determined by having a single investigator measure the 2 echocardiographic examinations that were performed by the same sonographers from the 8 dogs selected to assess within-day repeatability. Measurements were performed at least 2 weeks apart with the investigator blinded to previous measurements. Intraobserver measurement variability was determined by having a single investigator measure 9 randomly selected echocardiographic studies (3 baseline, 3 after butorphanol, and 3 after atenolol) on 3 separate occasions. These measurements were separated by at least 1 week and the investigator was blinded to previous results. Interobserver measurement variability was determined by having 2 additional investigators (3 total) measure the echocardiographic variables from the same 9 randomly selected dogs. These investigators were blinded to the results of the previous measurements as well as the other investigators' measurements.
| Balloon valvuloplasty
Balloon valvuloplasty was performed in a standard fashion using fluoroscopic guidance. 18 Specific decisions on type of equipment used (eg, catheter type and size) were at the discretion of the attending clinician although the procedure was generally performed in a similar manner as follows. A vascular introducer was placed in the right jugular vein. After pressure assessment of the pulmonary artery and RV, a right ventriculogram was performed using a flow-directed angiographic catheter to allow for measurement of the PV annulus. Balloon size was based on multiplying the PV annulus diameter by a factor of 1.3-1.5. 18 Each dog had at least 2 inflations but, if necessary, repeat inflations were performed until resolution of the stenotic waist was observed. All balloons were inflated to between nominal and rated burst pressure and held for 3-5 seconds. If there was concern for an anomalous prepulmonic coronary artery based on a levophase angiogram or computed tomography and angiography study before BV, it was not attempted.
| Statistical analysis
All statistical analyses were performed using commercial software 
| RESULTS
Twenty-nine dogs were enrolled in our study. Of these, 2 dogs were excluded; 1 because of failure to return for the after atenolol examina- A summary of the echocardiographic data from 27 dogs with PS at baseline, after butorphanol, and after atenolol is presented in Table 1 and Figure 1 . Aside from a significant reduction in heart rate (P < .001) and CI (P = .025), there were no significant differences (all P > .05) in methods of assessment of PS severity (PV mean PG, PV max PG, VTI ratio, velocity ratio, or iPVA) or indices of RV systolic function (iTAPSE and RV S') after butorphanol. After atenolol, PV mean PG and PV max PG were significantly reduced (all P ≤ .047) compared with baseline and after butorphanol echocardiographic examinations. Whereas VTI ratio, velocity ratio, and iPVA did not demonstrate a significant difference (all P ≥ .12) after atenolol compared with baseline or after butorphanol. Heart rate and RV function quantified by iTAPSE, and RV S' were significantly reduced (all P ≤ .022) after atenolol compared with baseline. The max PG changed from >80 to <80 mm Hg in 8 of 27 dogs (30%) after atenolol whereas this occurred in 1 dog (4%) after butorphanol. Abbreviations: AV, aortic valve; iPVA, pulmonary valve area indexed to body surface area; iTAPSE, tricuspid annular plane systolic exclusion indexed to body weight; PG, pressure gradient; PV, pulmonary valve; RV S', peak systolic RV myocardial velocity at the lateral tricuspid annulus; VTI, velocity time integral. A summary of the echocardiographic data of the 21 dogs that underwent BV is presented in Table 2 . Compared with before BV (ie, the echocardiographic examination after atenolol), heart rate, PV mean PG, and PV max PG were all significantly (all P < .001) decreased after BV. Additionally, CI, VTI ratio, velocity ratio, iPVA, iTAPSE, and RV S' were all significantly (all P ≤ .031) increased after BV compared with before BV.
Significant linear correlations of PV max PG to iPVA (r = −0.63; P < .001), VTI ratio (r = −0.73; P < .001), and velocity ratio (r = −0.64; P < .001) were observed from the baseline echocardiographic studies (n = 27). Similar significant linear correlations of PV mean PG to iPVA (r = −0.62; P < .001), VTI ratio (r = −0.69; P < .001), and velocity ratio (r = −0.59; P < .001) were observed. Table 3 shows the results of the echocardiographic variability studies for the indices of PS severity. With the exception of withinday repeatability of iPVA (CV = 10.5%), all echocardiographic methods for assessing severity of PS had low variability (ie, ICC > 0.80 and CV < 10%) with regard to within-day repeatability, intraobserver measurement variability, and interobserver measurement variability.
| DISCUSSION
Our results supported our hypothesis that atenolol causes a decrease in the flow-dependent methods of assessment of PS severity (PV mean PG and PV max PG) but the less flow-dependent methods, VTI ratio, velocity ratio, and iPVA, would be unaffected. In contrast to our hypothesis, the sedative butorphanol (0.2-0.25 mg/kg IV) did not significantly alter the flow-dependent methods of assessment of PS severity. As proof-of-principal we were able to demonstrate that iPVA, velocity ratio, and VTI ratio were all significantly increased after BV in addition to documenting significant decreases in PV mean PG and PV max PG after BV. Lastly, our results showed that the measurement variability and within-day repeatability of the 5 indices of assessment of PS severity (PV mean PG, PV max PG, iPVA, velocity ratio, and VTI ratio) were well within clinically acceptable limits (ICC > 0.80, CV < 10%) or close (iPVA within-day repeatability CV = 10.5%).
Applying the continuity equation valve area (also called effective orifice area) concept to the PV in dogs with PS has not been comprehensively evaluated. However, the concept has been introduced and its advantages and disadvantages discussed in the veterinary literature. 9, 14 In humans with valvular aortic stenosis, AV area is routinely FIGURE 1 Pulmonary valve mean pressure gradient (PV mean PG) (A), PV maximum pressure gradient (PV max PG) (B), Velocity ratio (C), VTI ratio (D), and PV area indexed to body surface area (iPVA) (E) at baseline, 5-minutes after butorphanol (0.2-0.25 mg/kg IV), and 2-to-4 weeks after atenolol (1-1.5 mg/kg PO q12h) in 27 dogs with PS. No significant differences (P > .05) for any of the methods of assessment of PS severity were noted when comparing baseline to after butorphanol. After atenolol, PV mean PG and PV max PG were significantly reduced (all P ≤ .047) compared with baseline and after butorphanol. Velocity ratio, VTI ratio, and iPVA did not demonstrate a significant difference (all P ≥ .12) after atenolol compared with baseline or after butorphanol. Vmax, maximum blood velocity; AV, aortic valve; PV, pulmonary valve estimated using this equation with the proximal or subvalvular region serving as the reference location or alternate anatomic location for which to calculate SV and solve for the unknown stenotic valve area. 13 To provide a frame of reference, one of the authors has generated reference values for iPVA from 70 healthy dogs using Clinical challenging to obtain reliable pulsed-wave Doppler profiles from the proximal RV outflow tract. Clinical experience also suggests it would be easier to obtain more reliable pulsed-wave Doppler profiles and measurement of the AV diameter compared with the proximal RV outflow tract. In addition, we hoped to avoid the potential complicating finding of a subvalvular lesion in some dogs with PS. [20] [21] [22] Further, a previous study has demonstrated a strong agreement of SV and cardiac output between the aortic and pulmonary root using Doppler echocardiography. 23 The continuity equation valve area has been studied in dogs with subaortic stenosis 24, 25 and in an experimental canine model of supravalvular aortic stenosis. 11 These studies evaluated the continuity equation valve area for the left ventricular outflow tract primarily in the context of its ability to predict adverse outcomes, development of subaortic stenosis in adulthood, and CSA over a wide range of hemodynamic conditions. Our study was designed to evaluate the continuity equation valve area applied to the PV (and VTI/velocity ratio). Specifically, our primary goal was to study the effects of altering transvalvular flow on the conventional flowdependent pressure gradient-based methods and the less flowdependent methods of assessment of PS severity in a clinically relevant manner. We anticipated that the sedative butorphanol, the beta-blocker atenolol, and BV would sufficiently alter transvalvular flow, and thus studying its effects on various methods of assessment of PS severity would provide clinically useful information. As expected, we documented that the less flow-dependent methods of assessment of PS severity (iPVA, VTI ratio, and velocity ratio)
were unaffected by atenolol, whereas the flow-dependent despite documenting a mild decrease in heart rate and CI. There are Abbreviation: BV, balloon valvuloplasty. See Table 1 for the remainder of the key. *Before BV represents the after atenolol echocardiographic data.
# Non-normally distributed, median (interquartile range). Abbreviations: CV, coefficient of variation; ICC, intraclass correlation coefficient. See Table 1 for the remainder for the key.
several potential explanations for this finding. First, the reduction in transvalvular flow as quantified by CI, although statistically significant, was not to the same degree when compared to the reduction in CI after atenolol, and CI after atenolol was significantly decreased beyond that after butorphanol. This could potentially be explained by the lack of effect of butorphanol on RV systolic function, as iTPASE and RV S' were not significantly different after butorphanol compared with baseline. This lack of effect of butorphanol on RV systolic function was also demonstrated in a recent study 27 As proof-of-principal, the current study evaluated PS severity after BV. We demonstrated that, although iPVA, VTI ratio, and velocity ratio did not change after butorphanol or after atenolol, these indices were all significantly increased after BV as expected. In theory, there is strong potential value to evaluating PS severity after BV using iPVA (and VTI/velocity ratio). As previously opined in a discussion of the canine left ventricular outflow tract, 10 it is difficult to evaluate the success or failure of a balloon dilatation or surgery without understanding its effects on valve area. Balloon valvuloplasty, in addition to increasing valve area, is expected to increase transvalvular flow, in part, through improved ventricular systolic function (by reducing afterload). 9 This effect was illustrated in the current study with an increase in CI and RV systolic function noted after BV compared to before BV. Thus, favorable results after BV might be masked when solely assessed by PV mean or PV max PG. Results of the current study might raise some questions regarding the clinical utility of the different less flow-dependent indices and, specifically, which might be best suited for clinical practice. Velocity ratio is appealing because it is quick and easy to measure, and like VTI ratio, fewer measurements, and calculations are necessary compared with iPVA. However, velocity ratio ignores the contour and flow duration of the flow profiles compared with VTI ratio and iPVA, which serves as a potential disadvantage. 13 Although iPVA, in theory, is more accurate, one must account for its cumbersome calculations, lower repeatability/higher measurement variability noted in our study, the greater potential for measurement error when determining CSA of the AV, and the necessity to index to body size. Thus, VTI ratio might serve as a compromise that is more appealing for routine clinical use for assessment of PS severity in dogs because of its potential advantages compared to velocity ratio and iPVA.
Perhaps the most obvious limitation of our study is that without a gold standard, we cannot comment on the accuracy of specific methods of assessment of severity (or lack thereof ) and we cannot conclude that one method of assessment of PS severity is superior to another. This would require assessment by cardiac catheterization or advanced imaging that are unfortunately hindered by anesthesia, availability, and cost. However, our study design permits the evalua- Our study has additional limitations that should be addressed.
We did not exclude dogs diagnosed with a PFO or mild valvular regurgitation. Shunts or valvular regurgitation can compromise the accuracy of the continuity valve area equation because of unequal SV through each outflow tract. 9 However, there was a lack of evidence of hemodynamic importance in the 4 dogs diagnosed with a PFO, as only mild shunting was observed with agitated saline contrast studies and a lack of erythrocytosis was noted. This coupled with only the mild degree of regurgitation tolerated suggests these findings were unlikely to have an important impact on our results.
Another limitation is that a single sonographer did not perform all of the echocardiographic examinations in our study. Several cardiology residents or board-certified cardiologists performed echocar- 
